Suppr超能文献

重新评估基于包涵体的生产作为一种表达困难的重组蛋白的通用机会。

Reassessment of inclusion body-based production as a versatile opportunity for difficult-to-express recombinant proteins.

机构信息

a Institute of Bioprocess Engineering and Pharmaceutical Technology , University of Applied Sciences Mittelhessen , Giessen , Germany.

b Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Project group Bioresources , Giessen , Germany.

出版信息

Crit Rev Biotechnol. 2018 Aug;38(5):729-744. doi: 10.1080/07388551.2017.1398134. Epub 2017 Nov 10.

Abstract

The production of recombinant proteins in the microbial host Escherichia coli often results in the formation of cytoplasmic protein inclusion bodies (IBs). Proteins forming IBs are often branded as difficult-to-express, neglecting that IBs can be an opportunity for their production. IBs are resistant to proteolytic degradation and contain up to 90% pure recombinant protein, which does not interfere with the host metabolism. This is especially advantageous for host-toxic proteins like antimicrobial peptides (AMPs). IBs can be easily isolated by cell disruption followed by filtration and/or centrifugation, but conventional techniques for the recovery of soluble proteins from IBs are laborious. New approaches therefore simplify protein recovery by optimizing the production process conditions, and often include mild resolubilization methods that either increase the yield after refolding or avoid the necessity of refolding all together. For the AMP production, the IB-based approach is ideal, because these peptides often have simple structures and are easy to refold. The intentional IB production of almost every protein can be achieved by fusing recombinant proteins to pull-down tags. This review discusses the techniques available for IB-based protein production before considering technical approaches for the isolation of IBs from E. coli lysates followed by efficient protein resolubilization which ideally omits further refolding. The techniques are evaluated in terms of their suitability for the process-scale production and downstream processing of recombinant proteins and are discussed for AMP production as an example.

摘要

在微生物宿主大肠杆菌中生产重组蛋白通常会导致细胞质蛋白包涵体 (IB) 的形成。形成 IBs 的蛋白质通常被认为是难以表达的,而忽略了 IBs 可以成为它们生产的机会。IBs 具有抗蛋白水解降解的能力,并且包含高达 90%的纯重组蛋白,这不会干扰宿主代谢。这对于像抗菌肽 (AMP) 这样的宿主毒性蛋白尤其有利。IBs 可以通过细胞破碎后过滤和/或离心轻松分离,但从 IBs 中回收可溶性蛋白的传统技术很繁琐。因此,新方法通过优化生产工艺条件简化了蛋白回收,通常包括温和的复溶方法,这些方法要么在重折叠后增加产量,要么完全避免重折叠的必要性。对于 AMP 生产,基于 IB 的方法是理想的,因为这些肽通常具有简单的结构,易于重折叠。通过将重组蛋白融合到下拉标签上,可以实现几乎所有蛋白质的故意 IB 生产。本综述讨论了基于 IB 的蛋白生产的现有技术,然后考虑了从大肠杆菌裂解物中分离 IBs 的技术方法,以及高效的蛋白复溶方法,理想情况下避免了进一步的重折叠。这些技术根据其在重组蛋白的过程规模生产和下游处理中的适用性进行了评估,并以 AMP 生产为例进行了讨论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验